Huron Digital Pathology is pleased to announce that the company will now operate under the name Huron Technologies. This change reflects the company’s evolution and its expanding focus on developing advanced technologies for digital pathology and a broader range of scientific applications.
Since coming under new management in April 2022, Huron has strengthened its foundation, expanded its product portfolio, and positioned the business for long-term growth. The rebrand marks an important milestone in this transformation and better represents the full scope of the company’s capabilities and future direction.
Huron Technologies remains committed to delivering innovative, high-quality solutions while maintaining the trusted relationships it has built with customers, partners, and the broader scientific community.
Looking ahead, the company will continue investing in new technologies and capabilities that advance digital pathology and support the evolving needs of researchers and healthcare organizations worldwide.